1.Ukwandiswa ishishini: Yuyue zonyango re acquisition, 100% ubambe
Kutshanje, i-app yokukhangela ishishini ibonisa ukuba iJiangsu Lerun contact lens Co., Ltd. iye yatshintsha kwimizi-mveliso nezorhwebo, abaninizabelo bokuqala iJiangsu Hongyi Garden Construction Engineering Co., Ltd. kunye neDanyang xintongqiu optical glasses Co., Ltd. umnini-sabelo omtsha uYuyue wezonyango (002223) ubambe i-100%.Kuyafaneleka ukukhankanya ukuba kwango-2019, uYuyue uchithe phantse i-80 yezigidi zeeyuan ukufumana amashishini amabini oomatshini bamehlo.
2.NgoMeyi 24, i-website esemthethweni ye-Zhejiang Pharmaceutical Machinery Procurement Centre yakhupha isaziso kwi-ranking of warehousing yeziyobisi ngo-2021, kunye nolwazi olufanelekileyo lweemveliso eziphezulu ze-200 zabhengezwa ngokusemthethweni.I-Top10 yayilawulwa ziinkampani zamayeza ezizwe ngezizwe, kunye neetafile ze-clopidogrel bisulfate ezivela kwiQela le-China Stone Pharmaceutical Group kunye ne-Europe Italy Pharmaceutical Co., Ltd., inkampani yasekhaya yoxubo-mayeza, yayihlala kwi-Top11.
3.Phantsi kothotho lwemigaqo-nkqubo, amayeza asekhaya avelisa into entsha angenise ixesha lokuvuna, kwaye amashishini axuba amayeza nawo angenile kwixesha lotshintshiselwano lwempumelelo.Ngokutsho kwedatha ye-micnet, ukususela ngo-2011, phantse i-90 iklasi yasekhaya i-1 yamachiza amatsha (kubandakanywa neklasi ye-1 kunye ne-1.1, ngaphandle kwe-vaccines, efanayo ngezantsi) ivunyiwe ukuba idweliswe, kwaye iinkampani ze-15 zamachiza ziye zavuma iintlobo ezi-2 okanye ngaphezulu.Izibonelelo ze-pharma enkulu yemveli zivelele, kwaye i-Hengrui iqinile kwindawo yokuqala.Emva kwe-hausen, i-biotech eyintloko ayifuni kudlula, kwaye i-Baiji Shenzhou, i-Hehuang iyeza kunye ne-moreng pharmaceutical zibotshelelwe kwindawo yesithathu.
4.IGuangzhou Baiyunshan Pharmaceutical Group Co., Ltd., isebe leGuangzhou Pharmaceutical Group, elinye lamashishini aphezulu angama-500 ehlabathini, yabhengeza ngorhatya lwe-30 kaMeyi ukuba i-Baiyunshan Pharmaceutical General Factory ifumene ileta evela kwi-US FDA (oko kukuthi i-US Food. kunye noLawulo lweDrug) nge-29 kaMeyi evuma iipilisi ze-bys10 ukuba zisetyenziswe kulingo lwezonyango kunyango lwamathumba aqinileyo aqhubela phambili ngokudityaniswa kweRET okanye uguqulo.I-Baiyunshan Pharmaceutical General Factory iceba ukwenza ulingo lwezonyango oluvulelekileyo, lwamaziko amaninzi lwesigaba I seyeza elitsha kwezi zibonakaliso zingentla xa iimeko zihlangatyezwana kwixesha elizayo elingekude.
5.Imakethi yearhente yokuchasana iyakhula kwakhona.I-Kelun pharmaceutical iphumelele ukulinganisa kokuqala kunye neyeza le-Hengrui ukuya elwandle.Ngokutsho kwedatha ye-Intranet, ngo-2021, ukuthengiswa kwe-agent ye-terminal yokuchasana kumaziko onyango karhulumente e-China idlule i-17billion ye-yuan, ukunyuka konyaka-ngonyaka kwe-13.05%;IHengrui pharmaceutical, General Electric pharmaceutical kunye neYangtze River Pharmaceutical zibekwe phakathi kwezithathu eziphezulu;Umthamo wokuthengisa weemveliso ezintlanu ugqithise 1bhiliyoni yeyuan, ekhokelwa inaliti ye-iodixanol.Okwangoku, iintlobo ezili-10 zee-agent ezichaseneyo (iinkcazo ezingama-40) ziye zavavanywa, kwaye iodophor idibene neemeko zokuqokelela okuphakathi;Iindidi ezili-12 zee-agent ezichaseneyo (iinkcazo zemveliso ezingama-23) zikwimarike ukuze zihlolwe, kwaye i-Beite pharmaceutical yeyokuqala ukuyixelisa.
6.Nge-7 kaJuni, i-Huiyu pharmaceutical yabhengeza ukuba icandelo layo eliphantsi le-Seacross pharmaceuticals' prosafel injection ifumene imvume yokubhalisa e-UK, nto leyo eyayenza yaba lishishini lokuqala ukufumana imvume yechiza elenziwe lafana nelo elenziwe lafana nelo e-UK.Ukusukela kulo nyaka, iimveliso ze-Huiyu zamachiza ziye zavunywa ekhaya nakwamanye amazwe.
7.I-200 yokuqala yokulinganisa iya kuvunywa!Iimveliso zokulinganisa ezishushu zeenkampani ezinkulu zavezwa.
Kwiminyaka yakutshanje, amayeza enziwe afana nalawo enziwe afana nalawo aveliswe ngabenzi bokuqala akhuthaziwe kwinqanaba likazwelonke.Ngelixa sisasaza amayeza amatsha, iinkampani eziphambili zamayeza ezinenqanaba eliphezulu le-R & D nazo ziwukhawulezisile umsebenzi “wokulinganisa”.Ukusukela ngo-2018, kukho malunga neemveliso ezingama-200 eziye zafaka isicelo sokuxelisa uluhlu kwaye ziphantsi koqwalaselo, kwaye akukho mvume yasekhaya ifunyenweyo kwiimveliso ezifanayo.Kulindeleke ukuba zivunywe ukuba zifakwe kuluhlu emva kwe-2022, kunye nobushushu obuphezulu beebhiliyoni ezingamakhulu amahlanu.
8.I-Humanwell ibonisa amandla ayo!Amachiza amatsha odidi loku-1 kunye namachiza amatsha aphuculweyo ali-18 ashushu.
Kwiminyaka yakutshanje, i-humanwell pharmaceutical, inkokeli ye-anesthesia kunye ne-sedation, iye yaphucula ngokuqhubekayo kwaye yadibanisa ukhuphiswano lwayo oluphambili "ngokugxila, ukusungula izinto ezintsha kunye nehlabathi".Kutshanje, inkampani ibhengeze ukuba iya kuchitha ngaphezulu kwe-1.6 yebhiliyoni ye-yuan yokuthenga iimpahla zepropati ukudibanisa izixhobo zangaphakathi kunye nokwandisa amandla ayo.Phakathi kwazo, ii-asethi zepropathi ezithengiweyo liziko lophando lweziyobisi kunye neziko lophuhliso ziya kusetyenziswa njengesiseko se-biomedical "yorhwebo olukhulu kunye ne-innovation" ukunyusa uyilo lokuyila.Kwisiqingatha sokuqala sika-2022, inkampani inamachiza amabini odidi loku-1 angakumbi avunyiweyo ukuba asetyenziswe eklinikhi, kwaye ichiza elitsha eliphuculweyo lokuqala lileqa emarikeni.Ukulinganisa kokuqala kweepilisi ze-chlorbazam zeziyobisi zabantwana ziye zatsala ingqalelo enkulu.Ukongeza, iimveliso ezintathu eziphambili sele ziza kudibana nebhetshi yesixhenxe yokufunyanwa kweSizwe.
9.Zhengda ilanga!I-58 iklasi ye-1 yamachiza amatsha kunye ne-9 yokuqala yokulinganisa i-sprints.
Kungekudala, umgca wemveliso weZhengda Tianqing amayeza uye wenza inkqubela entsha: ukuveliswa kwe-tq-b3101 capsule, iklasi entsha ye-1 anti-tumor drug, yabikwa, ithebhulethi yesithathu ye-sophopovir yasekhaya yavunywa, kunye ne-tqc2938 injection, iklasi entsha ye-1. iyeza elichasene ne-asthma, livunyiwe ukuba lisetyenziswe ekliniki Okwangoku, i-Zhengda Tianqing Pharmaceutical Co., Ltd. inamachiza amatsha angama-73 (i-58 iklasi ye-1 yamachiza amatsha) kwinqanaba lesicelo seklinikhi okanye ngaphezulu, apho i-14 yamachiza amatsha (i-5 iklasi ye-1 entsha iziyobisi) zikwisigaba se-III okanye ngaphezulu, kwaye uluhlu lulindelekile;Ngokubhekiselele kumachiza enziwe afana nalawo aveliswe ngabenzi, iindidi ezingama-54 ziye zavavanywa (ezingama-21 zezokuqala), amayeza asi-8 afakiwe kwibhetshi yesixhenxe yokuthengwa kwezinto ezikwindawo enye, kwaye ezili-15 ezisanda kubhaliswa nezibhengeziweyo ziphantsi koqwalaselo, ezisi-9 zazo azikavunywa. okokuqala (kubandakanya ikopi yokuqala yefom yedosi).
JinDun Medicalinentsebenziswano yexesha elide yophando lwezenzululwazi kunye neteknoloji yokuxhunyelelwa kwiiyunivesithi zaseTshayina.Ngezixhobo zonyango ezityebileyo zikaJiangsu, inobudlelwane bexesha elide kunye neIndiya, iSoutheast Asia, iSouth Korea, iJapan kunye nezinye iimarike.Ikwabonelela ngeenkonzo zentengiso kunye nentengiso kuyo yonke inkqubo ukusuka phakathi ukuya kwimveliso egqityiweyo ye-API.Sebenzisa izibonelelo eziqokelelweyo zeYangshi Chemical kwichemistry fluorine ukubonelelaiinkonzo ezizodwa zokwenza imichizakumaqabane.Ukubonelela ngenkqubo yokuveliswa kwezinto ezintsha kunye neenkonzo zophando lokungcola kubathengi abajoliswe kuyo.
Ixesha lokuposa: Nov-09-2022